We previously generated the anti-human IL-19 mAb 1BB1, which showed specific neutralization activity against human IL-19 in a mouse model of breast cancer (39, 40), but 1BB1 did not effectively neutralize mouse IL-19 protein in vivo (data not shown). Here, IL19 is linked to breast carcinoma.